Perspective Therapeutics (CATX) Loans - Net (2022)
Perspective Therapeutics recorded quarterly Loans - Net of $6.1 million in Q4 2022.
Perspective Therapeutics' Loans - Net history runs 1 years deep, the most recent figure standing at $6.1 million for Q4 2022.
- In Q4 2022, Loans - Net changed N/A year-over-year to $6.1 million; the TTM figure through Dec 2022 stood at $6.1 million (changed N/A YoY), while the FY2022 annual figure was $6.1 million, changed N/A from the prior year.
- Loans - Net came in at $6.1 million for Q4 2022 at Perspective Therapeutics.
- In the past five years, Loans - Net ranged from a high of $6.1 million in Q4 2022 to a low of $6.1 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 6.11 Mn |
| Dec 31, 2022 | 6.11 Mn |